Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Case Report: Diaphragm Ultrasound Reveals Shrinking Lung Syndrome

Mery Deeb, MD, Taro Minami, MD, Michael Stanchina, MD, Elias Jabbour, MD, & Jan Karczewski, MD  |  Issue: July 2024  |  

In Sum

Shrinking lung syndrome continues to be under-recognized overall, although awareness of the condition has increased over the past few years. Contrary to popular belief, shrinking lung syndrome could be an early feature of SLE. We should keep a high index of suspicion among patients with connective tissue disease who present with dyspnea, pleuritic chest pain and elevation of the diaphragm.

Although PFTs and chest CT remain essential to the diagnosis, diaphragm ultrasound can help confirm diaphragmatic dysfunction and supports a shrinking lung syndrome diagnosis, particularly in challenging cases. Given the potential for chronic restrictive lung physiology, early diagnosis may minimize long-term respiratory dysfunction.

ADVERTISEMENT
SCROLL TO CONTINUE

Mery Deeb, MD, is a resident in internal medicine at the Department of Medicine, Brown University, Providence, R.I., and Kent Hospital, Warwick, R.I.

Taro Minami, MD, is with the Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Warren Alpert Medical School of Brown University, Providence, R.I.

ADVERTISEMENT
SCROLL TO CONTINUE

Michael Stanchina, MD, is with the Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Warren Alpert Medical School of Brown University, Providence, R.I., and the Division of Pulmonary/Critical Care Medicine, Brigham and Women’s Hospital, Boston, and Care New England Hospitals, Rhode Island.

Elias Jabbour, MD, is with the Division of Pulmonary/Critical Care Medicine, Brigham and Women’s Hospital, Boston, and Care New England Hospitals, Rhode Island.

Jan Karczewski, MD, is with the Division of Rheumatology, Kent Hospital, Warwick, R.I.

Disclosures

Dr. Minami served as a consultant for Fujifilm (until 2023) and AA Health Dynamics (until January 2024) to teach point-of-care ultrasound in Kenya, a project funded by Ministry of Economy, Trade and Industry.

References

  1. Hoffbrand BI, Beck ER. ‘Unexplained’ dyspnoea and shrinking lungs in systemic lupus erythematosus. Br Med J. 1965 May 15;1(5445):1273–1277.
  2. Hoffman BJ. Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus. Arch Dermatol Syphilol. 1945;51(3):190–192.
  3. Minami T, Manzoor K, McCool FD. Assessing diaphragm function in chest wall and neuromuscular diseases. Clin Chest Med. 2018 Jun;39(2):335–344.
  4. McCool FD, Tzelepis GE. Dysfunction of the diaphragm. N Engl J Med. 2012 Mar 8;366(10):932–942.
  5. Yamada T, Minami T, Yoshino S, et al. Diaphragm ultrasonography: Reference values and influencing factors for thickness, thickening fraction, and excursion in the seated position. Lung. 2024 Feb;202(1):83–90.
  6. Borrell H, Narváez J, Alegre JJ, et al. Shrinking lung syndrome in systemic lupus erythematosus: A case series and review of the literature. Medicine (Baltimore). 2016 Aug;95(33):e4626.
  7. Henderson LA, Loring SH, Gill RR, et al. Shrinking lung syndrome as a manifestation of pleuritis: A new model based on pulmonary physiological studies. J Rheumatol. 2013 Mar;40(3):273–281.
  8. Hawkins P, Davison AG, Dasgupta B, et al. Diaphragm strength in acute systemic lupus erythematosus in a patient with paradoxical abdominal motion and reduced lung volumes. Thorax. 2001 Apr;56(4):329–330.
  9. Laroche CM, Mulvey DA, Hawkins PN, et al. Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med. 1989 May;71(265):429–439.
  10. DeCoste C, Mateos-Corral D, Lang B. Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: A case report and review of the literature. Pediatr Rheumatol Online J. 2021 Jan 6;19(1):7.
  11. Goswami RP, Mondal S, Lahiri D, et al. Shrinking lung syndrome in systemic lupus erythematosus successfully treated with rituximab. QJM. 2016 Sep;109(9):617–618.
  12. Langenskiöld E, Bonetti A, Fitting JW, et al. Shrinking lung syndrome successfully treated with rituximab and cyclophosphamide. Respiration. 2012;84(2):144–149.
  13. Peñacoba Toribio P, Córica Albani ME, Mayos Pérez M, Rodríguez de la Serna A. Rituximab in the treatment of shrinking lung syndrome in systemic lupus erythematosus. Reumatol Clin. 2014 Sep-Oct;10(5):325–327.

Related Articles
    Medium-sized blood vessels are seen in the dermis and at the dermal-subcutaneous junction. The black arrow identifies a venule, and the blue arrow points to a fibrin deposition in the vessel wall. Extravasated neutrophils and erythrocytes are seen in the interstitium.

    Case Report: A Polyarteritis Nodosa Conundrum

    Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis that typically affects medium-sized muscular arteries. The clinical subsets of PAN are idiopathic, generalized, secondary hepatitis B virus (HBV) associated and cutaneous PAN. These clinical subsets are important because of their therapeutic implications. Virtually any organ system can be affected in generalized PAN, but this vasculitis tends…

    Case Report: Perplexing Pulmonary Nodules

    Pulmonary nodules are com­mon; most are benign, but the differential diagnosis is broad and includes life-threatening possibilities.1 Our patient is a former smoker who has a history of a complex autoimmune disease and multiple pulmonary nodules. This case was challenging, but clinical, radiographic and histologic clues helped lead to the correct diagnosis. Case Presentation The…

    APS: What Rheumatologists Should Know about Hughes Syndrome

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    Case Report: Interstitial Lung Disease with Positive ANCA Test

    “Worst of all is the pain in my calves,” she said. “It feels like burning deep inside.” So began my first encounter with a 69-year-old woman who was referred to rheumatology clinic for evaluation of two months of constitutional symptoms and a positive ANCA test, which had been ordered by her primary care doctor. Her…